Search
Patexia Research
Case number 1:21-cv-00314

Bayer Pharma AG et al v. Lupin Limited et al > Documents

Date Field Doc. No.Description (Pages)
Jul 27, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 68 in 21-md-3017-RGA; D.I. 92 in 21-cv-314-RGA-JLH; D.I.93 in 21-cv-1742-RGA) Joint Stipulation and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 7/27/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms)
Jul 26, 2022 92 Stipulation to EXTEND Time (3)
Docket Text: Joint Stipulation and Proposed Order to Extend Time - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd.. (Ormerod, Eve) Modified on 7/27/2022 (nms).
Jul 12, 2022 91 Order (2)
Docket Text: SO ORDERED Granting (D.I. 66 in 21-md-3017-RGA; D.I. 90 in 21-cv-314-RGA-JLH) Stipulation of Dismissal (*Micro Labs USA, Inc. and Micro Labs Limited terminated). Signed by Judge Richard G. Andrews on 7/12/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
Jul 6, 2022 89 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Lupin's First Set of Requests for Production to Plaintiffs (Nos. 1-2) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Jul 6, 2022 90 Stipulation of Dismissal (2)
Docket Text: STIPULATION of Dismissal with prejudice, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/7/2022 (nms).
Jul 1, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 88 in 21-cv-314-RGA-JLH; D.I. 64 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order (between Plaintiffs and Defendants "Micro"). Signed by Judge Richard G. Andrews on 7/1/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms)
Jul 1, 2022 88 Stipulation (2)
Docket Text: STIPULATION to Amend the Scheduling Order (between Plaintiffs and Micro Labs), by Micro Labs Ltd., Micro Labs USA Inc.. (Hitch, Cortlan) Modified on 7/1/2022 (nms).
Jun 27, 2022 87 Order (2)
Docket Text: SO ORDERED Granting (D.I. 62 in 21-md-3017-RGA: D.I. 86 in 21-cv-314-RGA-JLH) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 6/27/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
Jun 24, 2022 86 Stipulation (2)
Docket Text: STIPULATION Amend Scheduling Order as to Plaintiffs and Micro Labs by Micro Labs Ltd.. (Hitch, Cortlan)
Jun 10, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 61 in 21-md-3017-RGA; D.I. 85 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 6/10/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
Jun 10, 2022 85 Motion for Leave to Appear Pro Hac Vice (3)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve)
Jun 9, 2022 84 Notice (Other) (1)
Docket Text: NOTICE of Withdrawal of Appearance of Anandita Vyakarnam by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. (Ormerod, Eve)
Jun 8, 2022 83 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s 1) Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-43) and 2) Responses and Objections to Plaintiffs' First Joint Set of Interrogatories (Nos. 1-7) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve)
Jun 7, 2022 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: The notice of service filed at D.I. 79 has been removed from the docket as the filing lacked reference to the MDL that this case is a member with. Defendants are to refile a corrected notice. (nms)
Jun 7, 2022 81 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of 1. Teva's Objections and Responses to Plaintiffs' First Set of Interrogatories 2. Teva's Objections and Responses to Plaintiffs' First Set of Requests for Production (Nos. 1 - 43) filed by Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan)
Jun 7, 2022 82 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of 1) Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Response to Plaintiffs' First Joint Set of Interrogatories; and 2) Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Response to Plaintiffs' First Set of Requests for Production filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert)
Jun 6, 2022 80 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Lupin's Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-7) and Lupin's Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-43) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Jun 2, 2022 77 Stipulation (2)
Docket Text: STIPULATION to Amended Scheduling Order by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth)
Jun 2, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 77 in 21-cv-314-RGA-JLH; D.I. 53 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 6/2/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
Jun 1, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Frank D. Rodriguez for Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
Jun 1, 2022 76 Notice of Service (8)
Docket Text: NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Responses and Objections to Defendants' First Set of Joint Requests for Production (Nos. 1-60); (2) Plaintiffs Bayer Pharma AG and Bayer AG's Responses to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-9); (3) Plaintiff Janssen Pharmaceutical Inc.'s Responses and Objections to Defendants' First Set of Joint Requests for Production (Nos. 1-60); and (4) Plaintiff Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-9) filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
May 31, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 51 in 21-md-3017-RGA; D.I. 75 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 5/31/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
May 31, 2022 75 Motion for Leave to Appear Pro Hac Vice (3)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve)
May 25, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 74 in 21-cv-314-RGA-JLH; D.I. 50 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp, filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. Signed by Judge Richard G. Andrews on 5/25/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
May 25, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney David M. Knapp for Taro Pharmaceutical Industries, Ltd. and Taro Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
May 24, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 71 in 21-cv-314-RGA-JLH; D.I. 47 in 21-md-3017-RGA; D.I. 88 in 21-cv-1742-RGA) STIPULATION and Proposed Order to Extend Time to Submit Joint Claim Construction Chart to May 24, 2022. Signed by Judge Richard G. Andrews on 5/24/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms)
May 24, 2022 72 Stipulation (3)
Docket Text: STIPULATION and [Proposed] Order regarding claim construction, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 5/24/2022 (nms).
May 24, 2022 N/A Order (0)
Docket Text: SO ORDERED Granting (D.I. 89 in 21-cv-1742-RGA; D.I. 72 in 21-cv-314-RGA-JLH; D.I. 48 in 21-md-3017-RGA) Stipulation and Proposed Order regarding claim construction (*The Markman hearing scheduled for 8/23/2022 is CANCELED). Signed by Judge Richard G. Andrews on 5/24/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms)
May 24, 2022 74 Motion for Leave to Appear Pro Hac Vice (5)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert)
May 23, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 46 in 21-md-3017-RGA; D.I. 70 in 21-cv-314-RGA-JLH) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 5/23/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
May 23, 2022 70 Stipulation (2)
Docket Text: STIPULATION to Amend the Scheduling Order by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth)
May 23, 2022 71 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME to Submit Joint Claim Construction Chart to May 24, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Haney, Megan)
May 20, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 45 in 21-md-3017-RGA; D.I. 69 in 21-cv-314-RGA-JLH; D.I. 87 in 21-cv-1742-RGA) STIPULATION and Proposed Order to Extend Time for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 23, 2022. Signed by Judge Richard G. Andrews on 5/20/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms)
May 19, 2022 69 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 23, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
May 18, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 85 in 21-cv-1742-RGA; D.I. 68 in 21-cv-314-RGA-JLH; D.I. 43 in 21-md-3017-RGA) STIPULATION and Proposed Order to Extend Time for deadlines related to claim construction briefing. Signed by Judge Richard G. Andrews on 5/18/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms)
May 17, 2022 68 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION and Proposed Order to Extend Time for deadlines related to claim construction briefing - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 5/18/2022 (nms).
May 13, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 66 in 21-cv-314-RGA-JLH; D.I. 40 in 21-md-3017-RGA) STIPULATION to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
May 13, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 83 in 21-cv-1742-RGA; D.I. 41 in 21-md-3017-RGA; D.I. 67 in 21-cv-314-RGA-JLH) STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 17, 2022. Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms)
May 13, 2022 66 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME various dates to dates listed in stipulation - filed by Micro Labs Ltd., Micro Labs USA Inc., Micro Labs Limited, Micro Labs USA, Inc.. (Dorsney, Kenneth)
May 13, 2022 67 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 17, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
May 2, 2022 64 Notice (Other) (6)
Docket Text: NOTICE of Change of Address for Williams & Connolly LLP by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc. (Fahnestock, Derek)
May 2, 2022 65 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants' Identification of Claim Terms and Constructions filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu)
Apr 29, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [62] Stipulation to Amend Scheduling Order between Plaintiffs and Defendants Micro Labs Limited and Micro Labs USA, Inc.. Signed by Judge Richard G. Andrews on 4/29/2022. (nms)
Apr 29, 2022 62 Stipulation (2)
Docket Text: STIPULATION to Amended Scheduling Order (between Plaintiffs and Micro Labs), by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) Modified on 4/29/2022 (nms).
Apr 29, 2022 63 Notice of Service (8)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Claim Construction Issue Identification - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
Apr 22, 2022 61 Notice of Service (13)
Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Joint Set of Interrogatories to Defendants, (2) Plaintiffs' First Set of Requests for Production to Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd., (3) Plaintiffs' First Set of Requests for Production to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc., (4) Plaintiffs' First Set of Requests for Production to Defendants Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc., (5) Plaintiffs' First Set of Requests for Production to Defendants Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc., (6) Plaintiffs' First Set of Requests for Production to Defendants Micro Labs Ltd. and Micro Labs USA, Inc., and (7) Plaintiffs' First Set of Requests for Production to Defendants Mylan Pharmaceuticals, Inc. and Mylan Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
Apr 18, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 59 in 21-cv-314-RGA-JLH; D.I. 33 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 4/18/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms)
Apr 18, 2022 59 Stipulation (2)
Docket Text: STIPULATION to Amend the Scheduling Order (between Plaintiffs and Micro Labs) by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth)
Apr 18, 2022 60 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants' First Set Of Joint Interrogatories To Plaintiffs (Nos. 1-9); and Defendants' First Set Of Joint Requests For Production To Plaintiffs (Nos. 1-60) filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu)
Apr 15, 2022 58 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery and (2) Janssen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the District of Delawares Default Standard for Discovery - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
Apr 4, 2022 N/A Case No Longer Referred to Mediation (0)
Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. § 652(b). Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(Taylor, Daniel)
Apr 1, 2022 57 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Initial Disclosures, (2) Janssen Pharmaceuticals, Inc.'s Initial Disclosures, and (3) Bayer Pharma AG, Bayer AG's, and Janssen Pharmaceuticals, Inc.'s Initial Identification of Asserted Patents and Accused Products and Methods - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
Mar 28, 2022 56 Objections (9)
Docket Text: Answer to Counterclaims of Defendants Micro Labs Ltd. and Micro Labs USA, Inc. (see C.A. 22-165-RGA, D.I. 10), by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/28/2022 (nms).
Mar 22, 2022 N/A Remark (0)
Docket Text: Remark: Civil Action 22-165-RGA has been added as a consolidated case per filing D.I. 13 on that docket. (nms)
Mar 2, 2022 54 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by David Ellis Moore on behalf of Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. (Moore, David)
Mar 2, 2022 55 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. (Palapura, Bindu)
Mar 1, 2022 53 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants' Joint Initial Invalidity Contentions with Ex. A filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu)
Jan 28, 2022 49 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for DRL's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
Jan 28, 2022 50 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Lupin's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
Jan 28, 2022 51 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Taro's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
Jan 28, 2022 52 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Teva's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
Dec 29, 2021 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: The Notice of Service filed by Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd. at D.I. 44 has been removed from the docket. This filing lacked reference in the caption to the MDL matter it relates with. Defendants shall correct the notice and refile in this action as well as the MDL. (nms)
Dec 29, 2021 45 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and Lupin Limited and Lupin Pharmaceuticals, Inc.'s Production of Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Phillips, John)
Dec 29, 2021 46 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Default Standard Paragraph 3 and 4(b) Disclosures filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve)
Dec 29, 2021 47 Notice of Service (8)
Docket Text: NOTICE OF SERVICE of Bayer Pharma AG and Bayer AG's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Bayer AG, Bayer Pharma AG.(Fahnestock, Derek)
Dec 29, 2021 48 Notice of Service (8)
Docket Text: NOTICE OF SERVICE of Janssen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
Dec 27, 2021 43 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of 1) Initial Disclosures of Taro Pharmaceutical Industries Ltd and Taro Pharmaceuticals U.S.A. Inc. Pursuant to Paragraph 3 of the Default Standard for Discovery; and 2) Taro Pharmaceutical Industries Ltd and Taro Pharmaceuticals U.S.A. Inc.'s core technical documents filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert)
Dec 20, 2021 42 Notice of Voluntary Dismissal (2)
Docket Text: NOTICE of Voluntary Dismissal by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc. as to Taro's Counterclaims as to U.S. Patent 9,415,053 (Without Prejudice) (Vrana, Robert)
Dec 17, 2021 41 Objections (13)
Docket Text: Answer to Answer to Complaint and Counterclaim, Bayer AG, Bayer Pharma AG, and Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/20/2021 (nms).
Dec 15, 2021 N/A Remark - MDL Notice to Counsel (0)
Docket Text: NOTICE TO COUNSEL: MDL No. 1:21-md-3017 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents and are not registered, should register for E-filing rights through PACER. Please see the docket for further entries. Associated Cases: 1:21-md-03017-RGA et al. (nmg)
Dec 15, 2021 N/A Remark - MDL Member (0)
Docket Text: NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:21-md-03017-RGA et al. (nmg)
Dec 15, 2021 39 Order (4)
Docket Text: CERTIFIED TRANSFER ORDER - issued by the Panel on the Multi-District Litigation on 12/10/2021. Associated Cases: 1:21-md-03017-RGA et al. (nmg)
Dec 15, 2021 40 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Rule 26(a)(1) Initial Disclosures filed by Mylan Pharmaceuticals Inc., Mylan Inc..(Palapura, Bindu)
Dec 13, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [38] STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Counterclaims. Signed by Judge Richard G. Andrews on 12/13/2021. (nms)
Dec 10, 2021 38 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Plaintiffs' Complaint for Patent Infringement and Counterclaims to December 17, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
Dec 6, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [35] STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Counterclaims to December 10, 2021. Signed by Judge Richard G. Andrews on 12/6/2021. (nms)
Dec 6, 2021 36 Proposed Order (30)
Docket Text: PROPOSED Stipulated Protective Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/6/2021 (nms).
Dec 6, 2021 37 Order (30)
Docket Text: SO ORDERED Granting [36] Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 12/6/2021. (nms)
Dec 3, 2021 35 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Plaintiffs' Complaint for Patent Infringement and Counterclaims to December 10, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
Nov 30, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [33] STIPULATION TO EXTEND TIME to submit a proposed Protective Order to December 6, 2021. Signed by Judge Richard G. Andrews on 11/30/2021. (nms)
Nov 29, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [32] STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Plaintiffs' Complaint for Patent Infringement and Counterclaims to December 3,2021. Signed by Judge Richard G. Andrews on 11/29/2021. (nms)
Nov 29, 2021 33 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to submit a proposed Protective Order to December 6, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
Nov 29, 2021 34 Notice of Service (7)
Docket Text: NOTICE OF SERVICE of Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.'s Initial Identification of Asserted Patents and Accused Products and Methods - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
Nov 24, 2021 32 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Plaintiffs' Complaint for Patent Infringement and Counterclaims to December 3, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
Nov 12, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [31] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Bayer AG answer due 11/24/2021; Bayer Pharma AG answer due 11/24/2021; Janssen Pharmaceuticals, Inc. answer due 11/24/2021). Signed by Judge Richard G. Andrews on 11/12/2021. (nms)
Nov 11, 2021 31 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 11/12/2021 (nms).
Nov 10, 2021 29 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Initial Disclosures of Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert)
Nov 10, 2021 30 Notice of Service (1)
Docket Text: NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Rule 26(a) Initial Disclosures filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd..(Ormerod, Eve)
Nov 9, 2021 28 Notice of Service (7)
Docket Text: NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Initial Disclosures and (2) Janssen Pharmaceuticals, Inc.'s Initial Disclosures filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
Nov 5, 2021 27 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Lupin's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Nov 3, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [26] MOTION for Pro Hac Vice Appearance of Attorney Jitty Malik, Ph.D., filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 11/3/2021. (nms)
Nov 3, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Jitty Malik, Ph.D. for Lupin Limited and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Nov 3, 2021 26 Main Document (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jitty Malik, Ph.D. - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Certification of Jitty Malik, Ph.D.)(Haney, Megan)
Nov 3, 2021 26 Certification of Jitty Malik, Ph.D. (1)
Oct 28, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Dov P. Grossman and Bruce R. Genderson for Bayer AG and Bayer Pharma AG added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Oct 27, 2021 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(Taylor, Daniel)
Oct 27, 2021 N/A Oral Order (0)
Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynge and her Law Clerk, Daniel Taylor (daniel_taylor@ded.uscourts.gov), to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 10/27/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(Taylor, Daniel)
Oct 27, 2021 N/A Case Referred to Magistrate Judge (0)
Docket Text: CASE REFERRED to Magistrate Judge Jennifer L. Hall to handle all discovery disputes including any that arise in connection with expert reports. (nms)
Oct 27, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [25] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Bayer AG answer due 11/11/2021; Bayer Pharma AG answer due 11/11/2021; Janssen Pharmaceuticals, Inc. answer due 11/11/2021). Signed by Judge Richard G. Andrews on 10/27/2021. (nms)
Oct 27, 2021 22 Scheduling Order (13)
Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. The case will be referred to a Magistrate Judge to handle all discovery disputes. The actions are consolidated for all purposes, including trial, and all papers shall be filed in C.A. 21-314 only. Joinder of Parties due by 8/5/2022. Amended Pleadings due by 3/1/2022. Fact Discovery completed by 10/28/2022. Joint Claim Construction Brief due by 8/5/2022. A Markman Hearing is set for 8/23/2022, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 5/19/2023, at 8:30 AM in Courtroom 6A. A Bench Trial is set to start 5/30/2023 at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 10/27/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms)
Oct 27, 2021 N/A Oral Order (0)
Docket Text: ORAL ORDER: The Rule 16(b) Conference scheduled for 10/28/2021, is CANCELED. Ordered by Judge Richard G. Andrews on 10/27/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms)
Oct 27, 2021 N/A Oral Order (0)
Docket Text: ORAL ORDER: A Motion for Teleconference to Resolve Discovery Dispute should be filed if counsel finds they are unable to resolve a discovery matter. The suggested text for this motion can be found in Judge Hall's portion of the Court's website, in the "Forms" tab, under the heading "Motion for Teleconference to Resolve Discovery/Protective Order Disputes." The dispute will thereafter be addressed in accordance with Judge Hall's discovery dispute procedures. ORDERED by Judge Jennifer L. Hall on 10/27/2021. (ceg)
Oct 27, 2021 25 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs Bayer Pharma AG, Bayer AG, and Janssen Pharmaceuticals, Inc. to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Plaintiffs' Complaint for Patent Infringement and Counterclaims (D.I. 11) to November 11, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
Oct 26, 2021 21 Main Document (15)
Docket Text: PROPOSED Scheduling Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Letter)(Blumenfeld, Jack) Modified on 10/26/2021 (nms).
Oct 26, 2021 21 Letter to The Honorable Richard G. Andrews (1)
Sep 27, 2021 20 Order Setting Scheduling Conference (1)
Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 10/28/2021, at 2:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/27/2021. (nms)
Aug 30, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (D.I. 18 in 21-cv-1000-RGA; D.I. 17 in 21-cv-1001-RGA; D.I. 19 in 21-cv-314-RGA; D.I. 14 in 21-cv-732-RGA) MOTION for Pro Hac Vice Appearance of Attorney Thomas D. Rein and Andrew T. Langford, filed by Janssen Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 8/30/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms)
Aug 27, 2021 19 Motion for Leave to Appear Pro Hac Vice (8)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Thomas D. Rein and Andrew T. Langford - filed by Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
Jun 30, 2021 18 Notice Requesting Removal of Co-Counsel (2)
Docket Text: NOTICE requesting Clerk to remove S. Isaac Olson as co-counsel. Reason for request: no longer with the firm. (Blumenfeld, Jack)
Jun 25, 2021 17 Notice Requesting Removal of Co-Counsel (1)
Docket Text: NOTICE requesting Clerk to remove Guylaine Hache as co-counsel. Reason for request: no longer associated with the case. (Haney, Megan)
May 24, 2021 16 Answer to Counterclaim (8)
Docket Text: ANSWER to [14] Answer to Complaint, and Counterclaims, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Blumenfeld, Jack) Modified on 5/24/2021 (nms).
May 4, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Jillian M. Schurr, Lance A. Soderstrom, Deepro R. Mukerjee for Lupin Limited,for Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
May 3, 2021 14 Answer to Complaint (22)
Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against All Plaintiffs, by Lupin Limited, Lupin Pharmaceuticals, Inc..(Phillips, John) Modified on 5/4/2021 (nms).
May 3, 2021 15 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Phillips, John)
Mar 16, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Dov P. Grossman, Alexander S. Zolan, Kathryn S. Kayali, and Julie L. Tavares, filed by Bayer Pharma AG, Bayer AG, and[13] MOTION for Pro Hac Vice Appearance of Attorney S. Isaac Olson, filed by Janssen Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 3/16/2021. (nms)
Mar 16, 2021 12 Motion for Leave to Appear Pro Hac Vice (8)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Dov P. Grossman, Alexander S. Zolan, Kathryn S. Kayali, and Julie L. Tavares - filed by Bayer AG, Bayer Pharma AG. (Fahnestock, Derek)
Mar 16, 2021 13 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney S. Isaac Olson - filed by Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
Mar 11, 2021 11 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by Megan C. Haney on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Haney, Megan)
Mar 8, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Lance A. Soderstrom, Deepro Mukerjee, Guylaine Hache and Jillian M. Schurr, filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 3/8/2021. (nms)
Mar 8, 2021 10 Main Document (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lance A. Soderstrom, Deepro Mukerjee, Guylaine Hache and Jillian M. Schurr - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Certification of Lance A. Soderstrom, # (2) Certification of Deepro Mukerjee, # (3) Certification of Guylaine Hache, # (4) Certification of Jillian M. Schurr)(Phillips, John)
Mar 8, 2021 10 Certification of Lance A. Soderstrom (1)
Mar 8, 2021 10 Certification of Deepro Mukerjee (1)
Mar 8, 2021 10 Certification of Guylaine Hache (1)
Mar 8, 2021 10 Certification of Jillian M. Schurr (1)
Mar 4, 2021 8 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Lupin Limited waiver sent on 3/3/2021, answer due 5/3/2021. (Fahnestock, Derek)
Mar 4, 2021 9 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Lupin Pharmaceuticals, Inc. waiver sent on 3/3/2021, answer due 5/3/2021. (Fahnestock, Derek)
Mar 3, 2021 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
Mar 2, 2021 7 Summons Issued - Electronic (2)
Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (amf)
Mar 1, 2021 1 Main Document (12)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3554685.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(amf)
Mar 1, 2021 1 Exhibit A (26)
Mar 1, 2021 1 Civil Cover Sheet (1)
Mar 1, 2021 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf)
Mar 1, 2021 3 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (amf)
Mar 1, 2021 4 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/29/2021. Date of Expiration of Patent: 1/31/2039. Thirty Month Stay Deadline: N/A* (*U.S. Patent No. 7,157,456 expires August 28, 2024.) (amf)
Mar 1, 2021 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (amf)
Mar 1, 2021 6 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (amf)
Mar 1, 2021 1 Complaint* (1)
Menu